While some anti-inflammatory drugs, such as anti-tumor necrosis factor agents, may be helpful in reducing symptomatic CD strictures,5 there is no pharmacologic agent that can treat purely fibrotic strictures.6 For this reason, antifibrogenic therapy is sought to avoid surgery. Here, TNF is linked to Cowden disease.